Contributed By Pakharenko & Partners (Kyiv)
Pharmaceutical companies must duly maintain accounting and management records of all transactions, including payments made to the healthcare professionals. Legislation does not provide for a mandatory requirement to disclose information on transfers and amounts of payments to the healthcare professionals. However, more and more companies do this on a voluntary basis. First of all it concerns companies that are members of an association, such as the Association Innovative Medicines, an association of foreign manufacturers of medicines. Every year, they report on all marketing transactions in favour of healthcare professionals, sponsorships, grants, etc. For instance, the company that is a member of AIPM is obliged to disclose information annually on items of value provided (directly or indirectly) to healthcare institutions or healthcare professionals.
Transparency requirements apply to the companies that are members of self-regulatory organisations, the statutes of which provide for such transparency as a mandatory requirement, irrespective whether such companies are foreign or local.